Assessment of antibacterial sale by using the Anatomic Therapeutic Chemical classification and Defined Daily Dose methodology in Moshi Municipality, northern Tanzania

Tanzania Journal of Health Research

Volumn 12, Issue 3, 2010, Pages 208-212

  van den Boogaard, J ^a,b   Semvua, H H ^b   Boeree, M J ^a   Aarnoutse, R E ^a   Kibiki, G S ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

Author keywords

Anatomic therapeutic chemical (ATC) classification; Antibacterial sale; Defined daily dose (DDD) methodology; Tanzania

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; LINCOSAMIDE DERIVATIVE; MACROLIDE; METRONIDAZOLE; NITROFURANTOIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; STREPTOGRAMIN DERIVATIVE; TETRACYCLINE DERIVATIVE; TINIDAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG CLASSIFICATION; DRUG LEGISLATION; DRUG MARKETING; DRUG USE; OUTPATIENT; PHARMACIST; PHARMACY; TANZANIA; TREND STUDY;

EID: 79961070825     PISSN: 18216404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Blomberg, B., Mwakagile, D.S., Urassa, W.K., Maselle, S.Y., Mashurano, M., Digranes, A., Harthug, S., Langeland, N. (2004) Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania. BMC Public Health 4:45. doi: 10.1186/1471-2458-4-45.
2. Byarugaba, D.K. (2004) A view on antimicrobial resistance in developing countries and responsible risk factors. International Journal of Antimicrobial Agents 24, 105-110.
3. Center for Pharmaceutical Management (2003) Strategies for Enhancing Access to Medicines Program. Access to essential medicines: Tanzania, 2001. Arlington, VA: Management Sciences for Health.
4. Ferech, M., Coenen, S., Malhotra-Kumar, S., Dvorakova, K., Hendrickx, E., Suetens, C. & Goossens, H. (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. Journal of Antimicrobial Chemotherapy 58, 401-407.
5. Hutchinson, J.M., Patrick, D.M., Marra, F., Ng, H., Bowie, W.R., Heule, L., Muscat, M. & Monnet, D.L. (2004) Measurement of antibiotic consumption: A practical guide to the use of the Anatomical Therapeutic Chemical classification and Defined Daily Dose system methodology in Canada. Canadian Journal of Infectious Diseases 15, 29-35.
6. Mbwasi, R. & Mlaki, W. (2008) Increasing access to medicines in Tanzania. Lancet 372, 205-206.
7. Okeke, I.N., Laxminarayan, R., Bhutta, Z.A., Duse, A.G., Jenkins, P., O'Brien, T.F., Pablos-Mendez, A. & Klugman, K.P. (2005a) Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infectious Diseases 5, 481-493.
8. Okeke, I.N., Klugman, K.P., Bhutta, Z.A., Duse, A.G., Jenkins, P., O'Brien, T.F., Pablos-Mendez, A. & Laxminarayan, R. (2005b) Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infectious Diseases 5, 568-580.
9. Radyowijati, A. & Haak, H. (2003) Improving antibiotic use in low-income countries: an overview of evidence on determinants. Social Science & Medicine 57, 733-744.
10. Van den Boogaard, J., Semvua, H.H., Boeree, M.J., Aarnoutse, R.E., Kibiki, G.S. (2010) Sale of fluoroquinolones in northern Tanzania: a potential threat for fluoroquinolone use in tuberculosis treatment. Journal of Antimicrobial Chemotherapy 65, 145-147.
11. WHO (2001) Who Global Strategy for Containment of Antimicrobial Resistance. WHO/CDS/CSR/DRS/2001.2a. 2001. Geneva, Switzerland.
12. WHO (2003) Introduction to Drug Utilization Research. World Health Organization, Geneva, Switzerland.